NEURO-BIO
Neuro-Bio is a start-up company focused on the development of novel, effective therapeutics for neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Motor Neuron Disease. The Company’s uniqueness lies in its innovative identification of the initial trigger of neurodegeneration - this has been developed throughout Baroness Professor Susan Greenfield’s highly credited 40 year career in neuroscience.
NEURO-BIO
Industry:
Biotechnology Health Care Neuroscience Therapeutics
Founded:
2013-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.neuro-bio.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0) 1235 420085
Email Addresses:
[email protected]
Total Funding:
3.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Current Employees Featured
Founder
Investors List
Kairos Ventures
Kairos Ventures investment in Series A - Neuro-Bio
Official Site Inspections
http://www.neuro-bio.com Semrush global rank: 4.68 M Semrush visits lastest month: 2.08 K
- Host name: 217-160-0-87.elastic-ssl.ui-r.com
- IP address: 217.160.0.87
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Neuro-Bio"
Neuro-Bio Has A Therapeutic Focus On Neurodegenerative …
Neuro-Bio is a privately owned biotech, spun out of Oxford University, with a therapeutic focus on neurodegenerative disease. The company has discovered a novel molecule (T14) which is …See details»
New Home Page - NeuroBio
Neuro-Bio is a privately owned biotech out of Oxford University with a therapeutic focus on neurodegenerative disease. The company has discovered a novel 14 amino acid bioactive peptide (T14) derived from the C terminus of AChE.See details»
Neuro-Bio - Crunchbase Company Profile & Funding
Neuro-Bio is a start-up company focused on the development of novel, effective therapeutics for neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Motor Neuron Disease. …See details»
Neuro-Bio Company History & Development Since …
Based on almost 40 years of research by Professor Baroness Greenfield at Oxford University, Neuro-Bio Ltd was incorporated in 2013, when seed …See details»
Neuro-Bio Ltd - LinkedIn
Neuro-Bio is a privately-owned biotech out of Oxford University with a therapeutic focus on neurodegenerative disease. ‘Neuro-Bio has discovered a novel 14 amino acid bioactive peptide (T14)...See details»
Neuro-Bio Company Profile 2024: Valuation, Funding & Investors
Developer of novel therapeutics designed to provide treatment of neurodegenerative disorders.See details»
NeuroBio - LinkedIn
At NeuroBio, we are leading the way to better medicines through predictive models, created by machine learning and biology at scale. We combine advanced AI and machine learning with cutting edge...See details»
Neuro-Bio - Products, Competitors, Financials, Employees, …
Neuro-Bio is a privately owned biotechnology company with a therapeutic focus on neurodegenerative diseases, particularly in the development of drugs for Alzheimer's disease. …See details»
Neuro-Bio - Funding, Financials, Valuation & Investors - Crunchbase
Neuro-Bio is funded by Kairos Ventures. Which investors participated in the most funding rounds?See details»
Novel Drug From Neuro-Bio Effective in a Mouse Model of …
Apr 6, 2022 · Neuro-Bio is a privately-owned biotech out of Oxford University with a focus on developing a first-in-class effective treatment for neurodegenerative disease. The company …See details»
An introduction to Neuro-Bio - YouTube
Neuro-Bio is a privately-owned biotech out of Oxford University focused on the discovery of oral drugs to treat Alzheimer’s diseaseSee details»
Neuro-Bio Company Organogram Structure & Personnel
Graphic of Neuro-Bio company structure, personnel and positions. For further information on Neuro-Bio please contact us.See details»
NeuroBio | AI Drug Development Platform | Artificial Neural …
At NeuroBio, we combine advanced AI and machine learning with innovative science to decipher complex disease biology and discover optimum therapeutic interventions. Our treatment …See details»
Novel drug from neuro-bio effective in a mouse model of …
Apr 6, 2022 · Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of …See details»
Neuro-Bio, a biotechnology company that develops treatments for …
Jan 12, 2022 · Neuro-Bio is a biotechnology company from the UK that develops treatments for Alzheimer’s disease (AD). The company is now looking to attract up to 10 million pounds …See details»
AskBio Welcomes Brain Neurotherapy Bio to Expand Clinical …
December 16, 2020 – Asklepios BioPharmaceutical, Inc. (AskBio) is pleased to announce that the clinical team from Brain Neurotherapy Bio, Inc., a gene therapy company based in Columbus, …See details»
Relevant Publications On Neurodegenerative Diseases
A wide range of publications available to download on neurodegenerative diseases and associated biotechnology areas. Call for further information.See details»
Novel drug from Neuro-Bio effective in a mouse model of …
Apr 6, 2022 · Neuro-Bio is a privately-owned biotech out of Oxford University with a focus on developing a first-in-class effective treatment for neurodegenerative disease. The company …See details»
About the NIH NeuroBioBank - National Institutes of Health
A not-for-profit organization, NDRI empowers mental health and neurological research and discovery through the procurement and distribution of human biospecimens worldwide.See details»
MDB Neuro
MDB Neuro is a preclinical CRO offering animal models, translational tools, and biomarkers for drug development in pain and CNS-related conditions.See details»